Company: MDCXW
Filing Date: 2025-03-28
Form Type: 253G2
Source: 0001062993-25-006502
Chunk: 44

Company: Medicus Pharma Ltd.
Filing Date: 2025-03-28
Form: 253G2
Chunk 44
---
 |     | Pending |     | University Of Pittsburgh of The Commonwealth System of Higher Education/Carnegie Mellon University  |
| Australia     |     | Microneedle arrays for cancer therapy applications |     |      2024256083 |     | 11/6/2014     |     | 11/6/2015  |     |            |     |            |     | 11/6/2035  |     | Pending |     | University Of Pittsburgh of The Commonwealth System of Higher Education/Carnegie Mellon University  |
| Korea         |     | Microneedle arrays for cancer therapy applications |     | 10-2022-7039076 |     | 11/6/2014     |     | 11/6/2015  |     |            |     |            |     | 11/6/2035  |     | Pending |     | University Of Pittsburgh of The Commonwealth System of Higher Education/Carnegie Mellon University  |
| Japan         |     | Microneedle arrays for cancer therapy applications |     |      2024189676 |     | 11/6/2014     |     | 11/6/2015  |     |            |     |            |     | 11/6/2035  |     | Pending |     | University Of Pittsburgh of The Commonwealth System of Higher Education/ Carnegie Mellon University |
| Singapore     |     | Microneedle arrays for cancer therapy applications |     |     1002004900T |     | 11/6/2014     |     | 11/6/2015  |     |            |     |            |     | 11/6/2035  |     | Pending |     | University Of Pittsburgh of The Commonwealth System of Higher Education/ Carnegie Mellon University |

Recent Developments TSXV Delisting On February 11, 2025, the Company announced that the Company's board of directors has approved the voluntary delisting of its common shares from the TSXV. Effective at the close of business on February 21, 2025, the Company's common shares were delisted from the TSXV. The Company's common shares will continue to be listed and trade on the Nasdaq under the symbol "MDCX". Standby Equity Purchase Agreement On February 10, 2025, the Company also announced that it had entered into a Standby Equity Purchase Agreement (the "SEPA") with